SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$69.45
2.06 (3.06%)
â˛
5d:
+8.09%
30d:
+14.34%
90d:
-13.0%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 19, 2026
25d
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SLGL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SLGL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $69.45, which is considered fair relative to its 30-day fair value range of $62.78 to $72.81.
Technical Outlook: Technically, SLGL is in a downtrend. Immediate support is located at $62.66, while resistance sits at $73.11. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SLGL scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $152.50 (+119.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLGL is in a downtrend. Immediate support is located at $62.66, while resistance sits at $73.11. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SLGL scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $152.50 (+119.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$62.78 -
$72.81
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 119.6% below Wall St target ($152.50)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.78 -
$72.81
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$62.66
Resistance Level
$73.11
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.65
Wall Street Target
$152.50
(+119.6%)
Revenue Growth (YoY)
-96.6%
Earnings Growth (YoY)
487.6%
Share & Embed Analysis
Last updated: October 24, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
Data refreshes hourly during market hours. Next update: 6:13 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 43 HOLD |
|
SNDX
Syndax Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$37 | 59 HOLD |
